Tag Archives: Human Genome Project

Nanotechnology and the US mega science project: BAM (Brain Activity Map) and more

The Brain Activity Map (BAM) project received budgetary approval as of this morning, Apr. 2, 2013 (I first mentioned BAM in my Mar. 4, 2013 posting when approval seemed imminent). From the news item, Obama Announces Huge Brain-Mapping Project, written by Stephanie Pappas for Yahoo News (Note: Links have been removed),

 President Barack Obama announced a new research initiative this morning (April 2) to map the human brain, a project that will launch with $100 million in funding in 2014.

The Brain Activity Map (BAM) project, as it is called, has been in the planning stages for some time. In the June 2012 issue of the journal Neuron, six scientists outlined broad proposals for developing non-invasive sensors and methods to experiment on single cells in neural networks. This February, President Obama made a vague reference to the project in his State of the Union address, mentioning that it could “unlock the answers to Alzheimer’s.”

In March, the project’s visionaries outlined their final goals in the journal Science. They call for an extended effort, lasting several years, to develop tools for monitoring up to a million neurons at a time. The end goal is to understand how brain networks function.

“It could enable neuroscience to really get to the nitty-gritty of brain circuits, which is the piece that’s been missing from the puzzle,” Rafael Yuste, the co-director of the Kavli Institute for Brain Circuits at Columbia University, who is part of the group spearheading the project, told LiveScience in March. “The reason it’s been missing is because we haven’t had the techniques, the tools.” [Inside the Brain: A Journey Through Time]

Not all neuroscientists support the project, however, with some arguing that it lacks clear goals and may cannibalize funds for other brain research.

….

I believe the $100M mentioned for 2014 would one installment in a series totaling up to $1B or more. In any event, it seems like a timely moment to comment on the communications campaign that has been waged on behalf of the BAM. It reminds me a little of the campaign for graphene, which was waged in the build up to the decision as to which two projects (in a field of six semi-finalists, then narrowed to a field of four finalists) should receive a FET (European Union’s Future and Emerging Technology) 1 billion euro research prize each. It seemed to me even a year or so before the decision that graphene’s win was a foregone conclusion but the organizers left nothing to chance and were relentless in their pursuit of attention and media coverage in the buildup to the final decision.

The most recent salvo in the BAM campaign was an attempt to link it with nanotechnology. A shrewd move given that the US has spent well over $1B since the US National Nanotechnology Initiative (NNI) was first approved in 2000. Linking the two projects means the NNI can lend a little authority to the new project (subtext: we’ve supported a mega-project before and that was successful) while the new project BAM can imbue the ageing NNI with some excitement.

Here’s more about nanotechnology and BAM from a Mar. 27, 2013 Spotlight article by Michael Berger on Nanowerk,

A comprehensive understanding of the brain remains an elusive, distant frontier. To arrive at a general theory of brain function would be an historic event, comparable to inferring quantum theory from huge sets of complex spectra and inferring evolutionary theory from vast biological field work. You might have heard about the proposed Brain Activity Map – a project that, like the Human Genome Project, will tap the hive mind of experts to make headway in the understanding of the field. Engineers and nanotechnologists will be needed to help build ever smaller devices for measuring the activity of individual neurons and, later, to control how those neurons function. Computer scientists will be called upon to develop methods for storing and analyzing the vast quantities of imaging and physiological data, and for creating virtual models for studying brain function. Neuroscientists will provide critical biological expertise to guide the research and interpret the results.

Berger goes on to highlight some of the ways nanotechnology-enabled devices could contribute to the effort. He draws heavily on a study published Mar. 20, 2013 online in ACS (American Chemical Society)Nano. Shockingly, the article is open access. Given that this is the first time I’ve come across an open access article in any of the American Chemical Society’s journals, I suspect that there was payment of some kind involved to make this information freely available. (The practice of allowing researchers to pay more in order to guarantee open access to their research in journals that also have articles behind paywalls seems to be in the process of becoming more common.)

Here’s a citation and a link to the article about nanotechnology and BAM,

Nanotools for Neuroscience and Brain Activity Mapping by A. Paul Alivisatos, Anne M. Andrews, Edward S. Boyden, Miyoung Chun, George M. Church, Karl Deisseroth, John P. Donoghue, Scott E. Fraser, Jennifer Lippincott-Schwartz, Loren L. Looger, Sotiris Masmanidis, Paul L. McEuen, Arto V. Nurmikko, Hongkun Park, Darcy S. Peterka, Clay Reid, Michael L. Roukes, Axel Scherer, Mark Schnitzer, Terrence J. Sejnowski, Kenneth L. Shepard, Doris Tsao, Gina Turrigiano, Paul S. Weiss, Chris Xu, Rafael Yuste, and Xiaowei Zhuang. ACS Nano, 2013, 7 (3), pp 1850–1866 DOI: 10.1021/nn4012847 Publication Date (Web): March 20, 2013
Copyright © 2013 American Chemical Society

As these things go, it’s a readable article for people without a neuroscience education provided they don’t mind feeling a little confused from time to time. From Nanotools for Neuroscience and Brain Activity Mapping (Note: Footnotes and links removed),

The Brain Activity Mapping (BAM) Project (…) has three goals in terms of building tools for neuroscience capable of (…) measuring the activity of large sets of neurons in complex brain circuits, (…) computationally analyzing and modeling these brain circuits, and (…) testing these models by manipulating the activities of chosen sets of neurons in these brain circuits.

As described below, many different approaches can, and likely will, be taken to achieve these goals as neural circuits of increasing size and complexity are studied and probed.

The BAM project will focus both on dynamic voltage activity and on chemical neurotransmission. With an estimated 85 billion neurons, 100 trillion synapses, and 100 chemical neurotransmitters in the human brain,(…) this is a daunting task. Thus, the BAM project will start with model organisms, neural circuits (vide infra), and small subsets of specific neural circuits in humans.

Among the approaches that show promise for the required dynamic, parallel measurements are optical and electro-optical methods that can be used to sense neural cell activity such as Ca2+,(7) voltage,(…) and (already some) neurotransmitters;(…) electrophysiological approaches that sense voltages and some electrochemically active neurotransmitters;(…) next-generation photonics-based probes with multifunctional capabilities;(18) synthetic biology approaches for recording histories of function;(…) and nanoelectronic measurements of voltage and local brain chemistry.(…) We anticipate that tools developed will also be applied to glia and more broadly to nanoscale and microscale monitoring of metabolic processes.

Entirely new tools will ultimately be required both to study neurons and neural circuits with minimal perturbation and to study the human brain. These tools might include “smart”, active nanoscale devices embedded within the brain that report on neural circuit activity wirelessly and/or entirely new modalities of remote sensing of neural circuit dynamics from outside the body. Remarkable advances in nanoscience and nanotechnology thus have key roles to play in transduction, reporting, power, and communications.

One of the ultimate goals of the BAM project is that the knowledge acquired and tools developed will prove useful in the intervention and treatment of a wide variety of diseases of the brain, including depression, epilepsy, Parkinson’s, schizophrenia, and others. We note that tens of thousands of patients have already been treated with invasive (i.e., through the skull) treatments. [emphases mine] While we hope to reduce the need for such measures, greatly improved and more robust interfaces to the brain would impact effectiveness and longevity where such treatments remain necessary.

Perhaps not so coincidentally, there was this Mar. 29, 2013 news item on Nanowerk,

Some human cells forget to empty their trash bins, and when the garbage piles up, it can lead to Parkinson’s disease and other genetic and age-related disorders. Scientists don’t yet understand why this happens, and Rice University engineering researcher Laura Segatori is hoping to change that, thanks to a prestigious five-year CAREER Award from the National Science Foundation (NSF).

Segatori, Rice’s T.N. Law Assistant Professor of Chemical and Biomolecular Engineering and assistant professor of bioengineering and of biochemistry and cell biology, will use her CAREER grant to create a toolkit for probing the workings of the cellular processes that lead to accumulation of waste material and development of diseases, such as Parkinson’s and lysosomal storage disorders. Each tool in the kit will be a nanoparticle — a speck of matter about the size of a virus — with a specific shape, size and charge.  [emphases mine] By tailoring each of these properties, Segatori’s team will create a series of specialized probes that can undercover the workings of a cellular process called autophagy.

“Eventually, once we understand how to design a nanoparticle to activate autophagy, we will use it as a tool to learn more about the autophagic process itself because there are still many question marks in biology regarding how this pathway works,” Segatori said. “It’s not completely clear how it is regulated. It seems that excessive autophagy may activate cell death, but it’s not yet clear. In short, we are looking for more than therapeutic applications. We are also hoping to use these nanoparticles as tools to study the basic science of autophagy.”

There is no direct reference to BAM but there are some intriguing correspondences.

Finally, there is no mention of nanotechnology in this radio broadcast/podcast and transcript but it does provide more information about BAM (for many folks this was first time they’d heard about the project) and the hopes and concerns this project raises while linking it to the Human Genome Project. From the Mar. 31, 2013 posting of a transcript and radio (Kera News; a National Public Radio station) podcast titled, Somewhere Over the Rainbow: The Journey to Map the Human Brain,

During the State of the Union, President Obama said the nation is about to embark on an ambitious project: to examine the human brain and create a road map to the trillions of connections that make it work.

“Every dollar we invested to map the human genome returned $140 to our economy — every dollar,” the president said. “Today, our scientists are mapping the human brain to unlock the answers to Alzheimer’s.”

Details of the project have slowly been leaking out: $3 billion, 10 years of research and hundreds of scientists. The National Institutes of Health is calling it the Brain Activity Map.

Obama isn’t the first to tout the benefits of a huge government science project. But can these projects really deliver? And what is mapping the human brain really going to get us?

Whether one wants to call it a public relations campaign or a marketing campaign is irrelevant. Science does not take place in an environment where data and projects are considered dispassionately. Enormous amounts of money are spent to sway public opinion and policymakers’ decisions.

ETA Ap. 3, 2013: Here are more stories about BAM and the announcement:

BRAIN Initiative Launched to Unlock Mysteries of Human Mind

Obama’s BRAIN Only 1/13 The Size Of Europe’s

BRAIN Initiative Builds on Efforts of Leading Neuroscientists and Nanotechnologists

Intellectual property, innovation, and hindrances

I have written many, many times about intellectual property and its stifling of innovation; my Oct. 31, 2011 posting titled, Patents as weapons and obstacles, probably rates as one of the more forthright pieces.

It seems that the argument (undertaken by many, many individuals and groups who have been tackling this issue for years before I ever heard it) is making itself felt amongst economists if this Mar. 27, 2013 news release on EurekAlert is to be believed,

A recent study published in the Journal of Political Economy suggests that some types of intellectual property rights discourage subsequent scientific research.

“The goal of intellectual property rights – such as the patent system – is to provide incentives for the development of new technologies. [emphases mine] However, in recent years many have expressed concerns that patents may be impeding innovation if patents on existing technologies hinder subsequent innovation,” said Heidi Williams, author of the study. “We currently have very little empirical evidence on whether this is a problem in practice.”

Williams investigated the sequencing of the human genome by the public Human Genome Project and the private firm Celera. Genes sequenced first by Celera were covered by a contract law-based form of intellectual property, whereas genes sequenced first by the Human Genome Project were placed in the public domain. Although Celera’s intellectual property lasted a maximum of two years, it enabled Celera to sell its data for substantial fees and required firms to negotiate licensing agreements with Celera for any resulting commercial discoveries.

By linking a number of different datasets that had not previously been used by researchers, Williams was able to measure when genes were sequenced, which genes were held by Celera’s intellectual property, and what subsequent investments were made in scientific research and product development on each gene. Williams’ conclusion points to a persistent 20-30 percent reduction in subsequent scientific research and product development for those genes held by Celera’s intellectual property.

“My take-away from this evidence is that – at least in some contexts – intellectual property can have substantial costs in terms of hindering subsequent innovation,” said Williams. “The fact that these costs were – in this context – ‘large enough to care about’ motivates wanting to better understand whether alternative policy tools could be used to achieve a better outcome. …

The Journal of Political Economy is publishing this research, is a University of Chicago Press journal which I expect adds a little cachet to the endeavour. Here’s a citation from the news release,

Heidi L. Williams, “Intellectual Property Rights and Innovation: Evidence from the Human Genome.” Journal of Political Economy 121:1 (publishing in February 2013 issue–due to release in April).

Quantum dots possibly toxic? And a followup to the Canadian 2009 budget and Genome Canada

After last week’s (and continuing into this week) excitement over Canadian scientists creating the smallest quantum dot ever, there’s an article about possible toxicity in Science Daily here. The gist of the article is that quantum dots which are used in solar cells, medical imaging devices, and elsewhere could decompose during use or after they’re disposed. In any event, the decomposed dots could release metals that are toxic when they are exposed to acidic and/or alkaline environments. According to the article, there’s no need to sound an alarm yet but it’s a good idea to keep an eye on the situation.

I made a comment abut mapping genomes when discussing the science funding cuts in the Canadian budget which featured Genome Canada’s complete disappearance [from the budget].  I referred to a comment by Denise Caruso (she was featured in a Project on Emerging Nanotechnologies webcast discussing synthetic biology here). I’ve reviewed the webcast and found that she wasn’t referring to genome mapping per se but was discussing something called the Encode Study which was four years long and funded by the Human Genome Project. It featured an international consortium of 80 organizations that were working together to create an encyclopedia of DNA elements. Here’s a rough transcription of her comments,

We have no idea what we’re talking about here. The genes don’t operate the way we thought they did. The genome is not a tidy collection of independent genes where the sequence of DNA does this [action] and always does this so we can put it on a shelf [and have it on a] parts inventory list. [The genes] operate within networks. What they [study participants] said was almost 180 degrees opposite to what we have believed for quite some time.

Rick Weiss who was interviewing her went on to describe how a genes that are seemingly unrelated signal each other in ways that we had not expected. Who knows how it all works in the environment i.e. when you get out of the lab?

So getting back to my original point, mapping is fine but it’s not the most primary goal. As per the webcast, it’s the relationships or networks that are important.

A quick note: the University of Virginia has a virtual lab that features information and podcasts about nano. You can go here to see it.